体检宫颈液基薄层细胞学684例结果分析被引量：1

在线阅读下载PDF

导出

摘要目的分析健康体检育龄妇女宫颈病变的现状,为进一步做好防癌普查提出合理化建议。方法 2012年4月—2013年9月在我中心体检育龄妇女684例自愿接受宫颈病变三阶梯诊断技术筛查,依2012年第二版《N C C N宫颈癌筛查指南》,由专业培训医师规范性取材,美国新柏氏液基薄层细胞学（TC T）制片,由细胞学专职医师进行TBS描述性报告方式报告结果。结果 684例宫颈病变筛查中,上皮内瘤变及宫颈癌高发年龄为36岁～45岁,接触性出血为主诉的筛查对象中阳性率明显高于其他自觉症状,肉眼观察宫颈光滑、外观无异常的高度病变（H SIL）、宫颈癌的发病率高于其他慢性宫颈炎。结论 36岁～45岁已婚育龄妇女为宫颈病变高发年龄,加强重点筛查,特别对临床上无自觉症状但妇科检查宫颈光滑、外观正常者不容忽视,应加强管理和随访。

作者张爱薇

机构地区临汾市尧都区人口和计划生育服务中心

出处《基层医学论坛》 2014年第14期1779-1781,共3页 The Medical Forum

关键词上皮内瘤变宫颈癌液基细胞学阴道镜

分类号 R737.33 [医药卫生—肿瘤]

引文网络
相关文献

参考文献3

1梁华茂.宫颈癌的病因学研究进展[J].中国全科医学,2010,13(29):3239-3241. 被引量：21
2崔晓莉,王纯雁,王红,康乐妮,陈汶,陈凤,于露露,洪恩宇,潘秦镜,乔友林.cobas 4800 HPV检测在宫颈癌筛查中的应用价值[J].中国肿瘤临床,2013,40(6):341-344. 被引量：9
3殷秀琴,王小菊,赵俊英,刘岩.液基细胞学检测及阴道镜检查诊断宫颈病变的临床意义[J].首都医科大学学报,2007,28(5):658-660. 被引量：18

二级参考文献41

1Erik Malmqvist, Gert Helgesson, Johannes Lehtinen, et al. The ethics of implementing human papillomavirus vaccination in developed countries (J ]. Medicine, Health Care, and Philosophy, Published online, 2010.
2Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases [ J ]. Public Health Genomics, 2009, 12:291-307.
3Collins S, Mazloomzadeh S, Winter H, et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship [ J ]. B JOG : An International Journal of Obstetrics and Gynaecology, 2002, 109: 96-98.
4Castellsague X, De Sanjose S, Aguado T, et al. HPV and Cervical Cancer in the World. 2007 Report. WHO/ICO information centre on HPV and cervical cancer (HPV Information Centre) [ R]. Vaccine, 2007, 25 (Suppl3) .
5Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis [J]. Lancet, 2005, 366:991-998.
6Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high - grade cervical lesions and cervical cancer: a meta - analysis [J]. BrJCancer, 2003, 89:101-105.
7Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high - grade cervical lesions : a meta - analysis update [ J ]. Int J Cancer, 2007, 121 : 621 - 632.
8Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999, 189: 12-19.
9Boscha FX, Burchellb AN, Schiffmanc M, et al. Epidemiology and natural history of human papillomavirus infections and type - specific implications in cervical neoplasia [J]. Vaccine, 2008, 26 (supplement 10) : K1 -K16.
10Kjaer SK, Frederiksen K, Mank C, et al. Long - term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence [ J ]. J Natl Cancer Inst, 2010, 102 : Epub ahead of print.